Acta Biochimica et Biophysica Sinica (Apr 2022)

Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus

  • Lv Yongxue,
  • Zhu Yazhou,
  • Chang Liangliang,
  • Yang Jihui,
  • Zhao Yinqi,
  • Zhao Jiaqing,
  • Wang Yana,
  • Zhu Mingxing,
  • Wu Changyou,
  • Zhao Wei

DOI
https://doi.org/10.3724/abbs.2022036
Journal volume & issue
Vol. 54
pp. 482 – 493

Abstract

Read online

Echinococcus granulosus causes echinococcosis, an important zoonotic disease worldwide and a major public health issue. Vaccination is an economical and practical approach for controlling E. granulosus. We have previously revealed that a recombinant protein P29 (rEg.P29) is a good vaccine candidate against E. granulosus. However, T cell immunogenic epitopes have not been identified. In the present study, we use rEg.P29-immunized mice as models to screen immunogenic epitopes for the construction of a novel multi-epitope vaccine. We search for immunodominant epitopes from an overlapping peptide library to screen the peptides of rEg.P29. Our results confirm that rEg.P29 immunization in mice elicits the activation of T cells and induces cellular immune responses. Further analyses show that a T cell epitope within amino acids 86–100 of rEg.P29 elicits significant antigen-specific IFN-γ production in CD4+ and CD8+ T cells and promotes specific T-cell activation and proliferation. Collectively, these results provide a reference for the construction of a novel vaccine against broad E. granulosus genotypes based on epitopes of rEg.P29.

Keywords